SMC HEALTHCARE

Specialized Medical Company

4019StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Operating Summary
Revenue	380.67M	406.91M	382.69M	379.96M	368.40M
Cost of Revenue	289.71M	323.31M	280.94M	278.05M	279.98M
Gross Profit	90.97M	83.60M	101.75M	101.91M	88.42M
SG&A	49.88M	11.77M	27.85M	53.33M	47.74M
Operating Expenses	49.88M	11.77M	27.85M	53.33M	47.74M
Operating Income	41.08M	71.83M	73.90M	48.58M	40.67M
Interest Expense	-10.36M	-4.92M	-12.39M	-13.02M	-12.15M
Other Income/Expense	2.98M	7.21M	6.98M	2.56M	2.61M
Pretax Income	33.70M	134.75M	68.49M	38.12M	31.14M
Income Tax	1.15M	0.77M	2.25M	1.76M	1.50M
Net Income	32.55M	133.98M	66.25M	36.36M	29.64M
EBITDA	57.71M	87.47M	90.07M	64.07M	55.83M
EBIT	41.08M	71.83M	73.90M	48.58M	40.67M
EPS (Basic)	0.13	0.54	0.26	0.15	0.12
EPS (Diluted)	0.13	0.54	0.26	0.15	0.12
Margins & Efficiency
Gross Margin %	+23.9%	+20.5%	+26.6%	+26.8%	+24.0%
EBITDA Margin %	+15.2%	+21.5%	+23.5%	+16.9%	+15.2%
Net Margin %	+8.6%	+32.9%	+17.3%	+9.6%	+8.0%
Revenue & Income
Revenue	380.67M	406.91M	382.69M	379.96M	368.40M
Revenue Growth (YoY)	+3.3%	+24.4%	-2.2%	+6.6%	+1.5%
Gain (Loss) on Sale of Assets	—	60.63M	—	—	—
Expenses & Provisions
Cost of Revenue	289.71M	323.31M	280.94M	278.05M	279.98M
Selling, General & Admin	49.88M	11.77M	27.85M	53.33M	47.74M
Operating Expenses	49.88M	11.77M	27.85M	53.33M	47.74M
Interest Expense	-10.36M	-4.92M	-12.39M	-13.02M	-12.15M
Other Non Operating Income (Expenses)	2.98M	7.21M	6.98M	2.56M	2.61M
D&A For EBITDA	16.63M	15.64M	16.17M	15.49M	15.15M
Profitability & Returns
Gross Profit	90.97M	83.60M	101.75M	101.91M	88.42M
Gross Margin	+23.9%	+20.5%	+26.6%	+26.8%	+24.0%
EBIT	41.08M	71.83M	73.90M	48.58M	40.67M
EBIT Margin	+10.8%	+17.7%	+19.3%	+12.8%	+11.0%
EBITDA	57.71M	87.47M	90.07M	64.07M	55.83M
EBITDA Margin	+15.2%	+21.5%	+23.5%	+16.9%	+15.2%
EBT Excluding Unusual Items	33.70M	74.12M	68.49M	38.12M	31.14M
Pretax Income	33.70M	134.75M	68.49M	38.12M	31.14M
Operating Income	41.08M	71.83M	73.90M	48.58M	40.67M
Operating Margin	+10.8%	+17.7%	+19.3%	+12.8%	+11.0%
Profit Margin	+8.6%	+32.9%	+17.3%	+9.6%	+8.0%
Net Income	32.55M	133.98M	66.25M	36.36M	29.64M
Net Income to Common	32.55M	133.98M	66.25M	36.36M	29.64M
Net Income Growth	+9.8%	+412.2%	+12.4%	-28.6%	-39.8%
Income Tax Expense	1.15M	0.77M	2.25M	1.76M	1.50M
Effective Tax Rate	+3.4%	+0.6%	+3.3%	+4.6%	+4.8%
Per Share & Capital
EPS (Basic)	0.13	0.54	0.26	0.15	0.12
EPS (Diluted)	0.13	0.54	0.26	0.15	0.12
EPS Growth	+9.8%	+412.2%	+12.4%	-28.6%	-39.8%
Dividend Per Share	—	0.32	—	—	—
Shares Change (YoY)	—	—	—	—	—
Shares Outstanding (Basic)	250.00M	250.00M	250.00M	250.00M	250.00M
Shares Outstanding (Diluted)	250.00M	250.00M	250.00M	250.00M	250.00M
Free Cash Flow	69.68M	116.58M	84.97M	-71.39M	98.13M
Free Cash Flow Margin	+18.3%	+28.7%	+22.2%	-18.8%	+26.6%
Free Cash Flow Per Share	0.28	0.47	0.34	-0.29	0.39
Payout Ratio	+614.4%	—	—	—	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Operating Summary
Revenue	380.67M	406.91M	382.69M	379.96M	368.40M
Cost of Revenue	289.71M	323.31M	280.94M	278.05M	279.98M
Gross Profit	90.97M	83.60M	101.75M	101.91M	88.42M
SG&A	49.88M	11.77M	27.85M	53.33M	47.74M
Operating Expenses	49.88M	11.77M	27.85M	53.33M	47.74M
Operating Income	41.08M	71.83M	73.90M	48.58M	40.67M
Interest Expense	-10.36M	-4.92M	-12.39M	-13.02M	-12.15M
Other Income/Expense	2.98M	7.21M	6.98M	2.56M	2.61M
Pretax Income	33.70M	134.75M	68.49M	38.12M	31.14M
Income Tax	1.15M	0.77M	2.25M	1.76M	1.50M
Net Income	32.55M	133.98M	66.25M	36.36M	29.64M
EBITDA	57.71M	87.47M	90.07M	64.07M	55.83M
EBIT	41.08M	71.83M	73.90M	48.58M	40.67M
EPS (Basic)	0.13	0.54	0.26	0.15	0.12
EPS (Diluted)	0.13	0.54	0.26	0.15	0.12
Margins & Efficiency
Gross Margin %	+23.9%	+20.5%	+26.6%	+26.8%	+24.0%
EBITDA Margin %	+15.2%	+21.5%	+23.5%	+16.9%	+15.2%
Net Margin %	+8.6%	+32.9%	+17.3%	+9.6%	+8.0%
Revenue & Income
Revenue	380.67M	406.91M	382.69M	379.96M	368.40M
Revenue Growth (YoY)	+3.3%	+24.4%	-2.2%	+6.6%	+1.5%
Gain (Loss) on Sale of Assets	—	60.63M	—	—	—
Expenses & Provisions
Cost of Revenue	289.71M	323.31M	280.94M	278.05M	279.98M
Selling, General & Admin	49.88M	11.77M	27.85M	53.33M	47.74M
Operating Expenses	49.88M	11.77M	27.85M	53.33M	47.74M
Interest Expense	-10.36M	-4.92M	-12.39M	-13.02M	-12.15M
Other Non Operating Income (Expenses)	2.98M	7.21M	6.98M	2.56M	2.61M
D&A For EBITDA	16.63M	15.64M	16.17M	15.49M	15.15M
Profitability & Returns
Gross Profit	90.97M	83.60M	101.75M	101.91M	88.42M
Gross Margin	+23.9%	+20.5%	+26.6%	+26.8%	+24.0%
EBIT	41.08M	71.83M	73.90M	48.58M	40.67M
EBIT Margin	+10.8%	+17.7%	+19.3%	+12.8%	+11.0%
EBITDA	57.71M	87.47M	90.07M	64.07M	55.83M
EBITDA Margin	+15.2%	+21.5%	+23.5%	+16.9%	+15.2%
EBT Excluding Unusual Items	33.70M	74.12M	68.49M	38.12M	31.14M
Pretax Income	33.70M	134.75M	68.49M	38.12M	31.14M
Operating Income	41.08M	71.83M	73.90M	48.58M	40.67M
Operating Margin	+10.8%	+17.7%	+19.3%	+12.8%	+11.0%
Profit Margin	+8.6%	+32.9%	+17.3%	+9.6%	+8.0%
Net Income	32.55M	133.98M	66.25M	36.36M	29.64M
Net Income to Common	32.55M	133.98M	66.25M	36.36M	29.64M
Net Income Growth	+9.8%	+412.2%	+12.4%	-28.6%	-39.8%
Income Tax Expense	1.15M	0.77M	2.25M	1.76M	1.50M
Effective Tax Rate	+3.4%	+0.6%	+3.3%	+4.6%	+4.8%
Per Share & Capital
EPS (Basic)	0.13	0.54	0.26	0.15	0.12
EPS (Diluted)	0.13	0.54	0.26	0.15	0.12
EPS Growth	+9.8%	+412.2%	+12.4%	-28.6%	-39.8%
Dividend Per Share	—	0.32	—	—	—
Shares Change (YoY)	—	—	—	—	—
Shares Outstanding (Basic)	250.00M	250.00M	250.00M	250.00M	250.00M
Shares Outstanding (Diluted)	250.00M	250.00M	250.00M	250.00M	250.00M
Free Cash Flow	69.68M	116.58M	84.97M	-71.39M	98.13M
Free Cash Flow Margin	+18.3%	+28.7%	+22.2%	-18.8%	+26.6%
Free Cash Flow Per Share	0.28	0.47	0.34	-0.29	0.39
Payout Ratio	+614.4%	—	—	—	—